Jiuzhitang Co., Ltd. (SHE:000989)

Market Cap	8.81B
Revenue (ttm)	1.96B
Net Income (ttm)	155.43M
Shares Out	846.28M
EPS (ttm)	0.18
PE Ratio	56.73
Forward PE	n/a
Dividend	0.30 (2.80%)
Ex-Dividend Date	May 8, 2025

Volume	13,196,106
Average Volume	41,801,905
Open	10.51
Previous Close	10.41
Day's Range	10.39 - 10.65
52-Week Range	6.26 - 13.30
Beta	0.48
RSI	41.10
Earnings Date	Aug 21, 2025

About Jiuzhitang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers Shuxuetong injections, Angong Niuhuang pills, Gastrodia Gouteng granules, Danxi granules, and Compound Jiangzhi tablets for cardiovascular and neurological treatment; Nudehua Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Analgesic capsules for the treatment in gynecology; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescript...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 3,689
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000989

Financial Performance

In 2024, Jiuzhitang's revenue was 2.37 billion, a decrease of -19.91% compared to the previous year's 2.96 billion. Earnings were 216.20 million, a decrease of -27.31%.